Literature DB >> 7140048

Etoposide--an effective single drug for treating bronchogenic carcinoma.

G Anderson, E T Peel, C M Cheong, N J Broderick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7140048

Source DB:  PubMed          Journal:  Clin Oncol        ISSN: 0305-7399


× No keyword cloud information.
  5 in total

1.  Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study.

Authors:  N Niederle; J Ostermann; W Achterrath; L Lenaz; C G Schmidt
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer.

Authors:  S Saxman; P J Loehrer; K Logie; D Stephens; F Workman; D Scullin; L H Einhorn; R Ansari
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

3.  Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Authors:  P Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer.

Authors:  U Gatzemeier; M Heckmayr; D K Hossfeld; R Zschaber; W Achterrath; L Lenaz
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Investigational trials of anticancer drugs: establishing safeguards for experimentation.

Authors:  B A Chabner; R Wittes; D Hoth; S Hubbard
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.